Trials / Sponsors / Cantex Pharmaceuticals
Cantex Pharmaceuticals
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Azeliragon in MGMT Unmethylated Glioblastoma Glioblastoma | Phase 2 | 2023-09-12 |
| Active Not Recruiting | Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma Glioblastoma | Phase 1 / Phase 2 | 2023-09-05 |
| Recruiting | Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer Metastatic Pancreatic Cancer | Phase 1 / Phase 2 | 2023-06-01 |
| Completed | Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma Recurrent Glioblastoma | Phase 2 | 2017-03-09 |